References
- Heesemann J. (1993). Mechanisms of resistance to beta-lactam antibiotics. Infection 21, S4–S9. Review. German.
- Hugonnet , J. E. , Tremblay , L. W. , Boshoff , H. I. , Barry , C. E. 3rd. and Blanchard , J. S. 2009 . Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis . Science , 323 : 1215 – 1218 .
- Kumar, V., Abbas, A. K., Fausto, N., Mitchell, R. N. (2007). Robbins Basic Pathology (8th ed.). Saunders Elsevier. 516–522.
- Lessel , J. 1996 . Penicillin–binding protein: The target for beta-lactam antibiotics, beta-lactamases and their inhibitors . Pharmazie in Unserer Zeit , 25 : 17 – 27 .
- WHO. (2010). Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response.
- Xu , H. , Hazra , S. and Blanchard , J. S. 2012 . NXL104 irreversibly inhibits the β-lactamase from Mycobacterium tuberculosis . Biochemistry , 51 : 4551 – 4557 .